BioSpace News Archive

FX received 510k clearances for their Glenoid Baseplate with a Central Screw and 32mm Glenosphere and Humeral Cups for reverse shoulder arthroplasty.

Paul Lévesque will be appointed as President and CEO, replacing Luc Tanguay , who is retiring

Taiho Oncology, Inc., announced today the support and sponsorship of vital awareness, research and patient access initiatives from leading colorectal cancer advocacy organizations, including Colorectal Cancer Alliance, Fight Colorectal Cancer and PALTOWN’s COLONTOWN ® , during National Colorectal Cancer Awareness Month in March.

KIYATEC, Inc. today announced that VA Portland Health Care System (VAPORHCS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to cancer therapies for patients with glioblastoma, an aggressive form of brain cancer.

UroGen Pharma Ltd. (Nasdaq:URGN) today announced financial results for the fourth quarter and full year ended December 31, 2019.

Ophirex, Inc., a public-benefit biotechnology company working to improve outcomes for global victims of snakebite, announced today that it has received a $2.5 million award from the Wellcome Trust’s £80 million (approximately $100 million) commitment to improve treatment of snakebite

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2019,

OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6 th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida.

At the request of Investment Industry Regulatory Organization of Canada, Correvio Pharma Corp. wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its common shares.

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.